LY294002

title: "LY294002" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["4-morpholinyl-compounds", "chromones", "phosphoinositide-3-kinase-inhibitors"] topic_path: "general/4-morpholinyl-compounds" source: "https://en.wikipedia.org/wiki/LY294002" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 443344935 | ImageFile = LY294002.svg | ImageClass = skin-invert-image | ImageSize = | PIN=2-(Morpholin-4-yl)-8-phenyl-4H-1-benzopyran-4-one | OtherNames=2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
| Section1 = {{Chembox Identifiers | IUPHAR_ligand = 6004 | CASNo_Ref = | CASNo=154447-36-6 | UNII_Ref = | UNII = 31M2U1DVID | PubChem=3973 | ChEMBL_Ref = | ChEMBL = 98350 | SMILES=C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4 | ChemSpiderID_Ref = | ChemSpiderID = 3835 | InChI = 1/C19H17NO3/c21-17-13-18(20-9-11-22-12-10-20)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13H,9-12H2 | InChIKey = CZQHHVNHHHRRDU-UHFFFAOYAM | StdInChI_Ref = | StdInChI = 1S/C19H17NO3/c21-17-13-18(20-9-11-22-12-10-20)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13H,9-12H2 | StdInChIKey_Ref = | StdInChIKey = CZQHHVNHHHRRDU-UHFFFAOYSA-N
| Section2 = {{Chembox Properties | C = 19 | H = 17 | N = 1 | O = 3 | Appearance = | Density = | MeltingPt = | BoilingPt = | Solubility =
| Section3 = {{Chembox Hazards | MainHazards = | FlashPt = | AutoignitionPt =
LY294002 is a morpholine-containing chemical compound that is a potent inhibitor of numerous proteins, and a strong inhibitor of phosphoinositide 3-kinases (PI3Ks). It is generally considered a non-selective research tool, and should not be used for experiments aiming to target PI3K uniquely.
Two of these are the proto-oncogene serine/threonine-protein kinase (PIM1) and the phosphatidylinositol-4,5-bisphosphate 3-kinase P110 gamma|catalytic subunit gamma isoform. With an IC50 of 1.4 μM it is somewhat less potent than wortmannin, another well-known PI3 kinase inhibitor. However, LY294002 is a reversible inhibitor of PI3K whereas wortmannin acts irreversibly.
Application of LY294002 causes a substantial acceleration of MEPP frequency (150 μM) at the frog neuromuscular junction through a mechanism that is independent of intraterminal calcium. LY294002 causes the release of MEPPs through a perturbation of synaptotagmin function.
LY294002 is also a BET inhibitor (e.g. of BRD2, BRD3, and BRD4).
Application
Research
It has been shown that LY294002 administration has an additive effect on quercetin antiviral activity against hepatitis C virus.
References
References
- (February 2009). "PI3K inhibitors for cancer treatment: where do we stand?". Biochemical Society Transactions.
- (August 2015). "The promise and peril of chemical probes". Nature Chemical Biology.
- "LY294002". DrugBank.
- (February 1994). "A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)". The Journal of Biological Chemistry.
- (December 2005). "LY 294002 inhibits adenosine receptor activation by a mechanism independent of effects on PI-3 kinase or casein kinase II". Purinergic Signalling.
- (February 2014). "The commonly used PI3-kinase probe LY294002 is an inhibitor of BET bromodomains". ACS Chemical Biology.
- (March 2014). "Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin". Laboratory Investigation; A Journal of Technical Methods and Pathology.
::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::